NURS 663 - COMPREHENSIVE FAMILY NURSE
PRACTITIONER (FNP) ROSH REVIEW |
MODULES 2-6 | 2026 UPDATED | 100% CORRECT.
145 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NURS 663 - COMPREHENSIVE FAMILY NURSE PRACTITIONER (FNP) ROSH REVIEW | MODULES 2-6 |
2026 UPDATED | 100% CORRECT.. It contains 145 carefully selected questions that reflect the most current
exam content and testing strategies. Each question is accompanied by a correct answer and a detailed rationale
that explains the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 145 Questions
Foundations - Application - NURS 663 Comprehensive Family Nurse Practitioner FNP ROSH Review
Modules 2 6 2026 Updated 100 Correct Family Nurse Practitioner Comprehensive Primary CARE ROSH
Review Modules 2 6 Graduate Msn/dnp Family Nurse Practitioner Program
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Advanced Health 1-25 Appropriate, Finding, Unilateral, Diabetes, Facial Droop
Assessment AND Diagnostic
Reasoning
Pharmacotherapeutics AND 26-50 Appropriate, Finding, Medication, Presents, Class
Prescriptive Authority
Health Promotion Disease 51-75 Appropriate, Reports, Acute, Presents, Daily
Prevention AND Patient
Education
Management OF Acute AND 76-100 Appropriate, According, Diabetes, Finding, Presents
Chronic Illness Across THE
Lifespan
Women S Health AND 101-125 Finding, Presents, History, Appropriate, Anemia
Prenatal/postpartum CARE
Pediatric AND Adolescent 126-145 Appropriate, Finding, Acute, Metformin, Presents
Primary CARE
TOTAL 145 All questions include answers and detailed rationales
,Section A - Advanced Health Assessment AND Diagnostic
Reasoning
Q1.
A patient with type 2 diabetes has an eGFR of 42 mL/min/1.73 m² and albuminuria. Which
medication class provides the strongest evidence for slowing CKD progression in this
scenario?
A. SGLT2 inhibitor B. Loop diuretic
C. Beta-blocker D. Calcium channel blocker
Correct: A - SGLT2 inhibitor
Rationale:SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin) have robust evidence for
slowing CKD progression and reducing cardiovascular events in diabetic kidney disease,
even in moderate renal impairment. Loop diuretics manage volume but do not slow
progression. Beta-blockers and calcium channel blockers lack primary renoprotective benefit
in this context.
Why the other answers are wrong:
B. Loop diuretics provide symptomatic volume control but do not confer renoprotection or slow
CKD progression.
C. Beta-blockers are used for cardiac indications and do not have primary evidence for slowing
diabetic kidney disease.
D. Calcium channel blockers may lower blood pressure but are not first-line for renoprotection
in diabetic CKD.
Reference: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD; ADA
Standards of Care 2026.
Q2.
A patient presents with sudden-onset unilateral facial droop, arm weakness, and slurred
speech that began 45 minutes ago. Which action is the immediate priority?
A. Administer aspirin 325 mg orally B. Activate emergency stroke protocol and
obtain non-contrast head CT
C. Obtain carotid ultrasound in the office D. Prescribe tissue plasminogen activator
(tPA) in the clinic
Correct: B - Activate emergency stroke protocol and obtain non-contrast head CT
Page 3
, Section A - Advanced Health Assessment AND Diagnostic Reasoning
Rationale: Acute stroke symptoms within the thrombolytic window require immediate
emergency activation and non-contrast head CT to rule out hemorrhage before any
reperfusion therapy. Aspirin is not given before imaging in acute stroke. Carotid ultrasound is
not emergent, and tPA is administered in a certified stroke center, not a primary care office.
Why the other answers are wrong:
A. Aspirin is contraindicated before ruling out hemorrhagic stroke and is not the immediate
priority.
C. Carotid ultrasound evaluates stenosis but is not part of acute stroke emergency
management.
D. tPA must be given in a hospital setting after imaging; the FNP's role is rapid recognition and
transfer.
Reference: AHA/ASA 2025 Guideline for the Early Management of Patients With Acute Ischemic Stroke.
Q3.
A patient with major depressive disorder has had inadequate response to an SSRI at
optimal dose for 8 weeks. Which is the most appropriate next step?
A. Add buspirone B. Switch to a different SSRI or SNRI
C. Augment with a low-dose antipsychotic D. Discontinue pharmacotherapy and start
psychotherapy alone
Correct: B - Switch to a different SSRI or SNRI
Rationale:After inadequate response to an adequate trial of an SSRI, switching to a different
SSRI or an SNRI is a recommended strategy. Augmentation with atypical antipsychotics or
adding buspirone are options for partial response, but switching is first-line when there is no
response. Monotherapy with psychotherapy alone is insufficient for moderate-to-severe
depression.
Why the other answers are wrong:
A. Buspirone augmentation is not first-line for inadequate SSRI response and has limited
evidence for depression.
C. Antipsychotic augmentation is typically reserved for partial response or treatment-resistant
depression after other steps.
D. Discontinuing pharmacotherapy is not recommended for moderate-to-severe depression;
combined treatment is preferred.
Reference: APA Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2025;
STAR*D findings.
Q4.
Which finding best supports a diagnosis of bacterial rather than viral conjunctivitis?
A. Bilateral watery discharge B. Preauricular lymphadenopathy
Page 4
PRACTITIONER (FNP) ROSH REVIEW |
MODULES 2-6 | 2026 UPDATED | 100% CORRECT.
145 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NURS 663 - COMPREHENSIVE FAMILY NURSE PRACTITIONER (FNP) ROSH REVIEW | MODULES 2-6 |
2026 UPDATED | 100% CORRECT.. It contains 145 carefully selected questions that reflect the most current
exam content and testing strategies. Each question is accompanied by a correct answer and a detailed rationale
that explains the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 145 Questions
Foundations - Application - NURS 663 Comprehensive Family Nurse Practitioner FNP ROSH Review
Modules 2 6 2026 Updated 100 Correct Family Nurse Practitioner Comprehensive Primary CARE ROSH
Review Modules 2 6 Graduate Msn/dnp Family Nurse Practitioner Program
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Advanced Health 1-25 Appropriate, Finding, Unilateral, Diabetes, Facial Droop
Assessment AND Diagnostic
Reasoning
Pharmacotherapeutics AND 26-50 Appropriate, Finding, Medication, Presents, Class
Prescriptive Authority
Health Promotion Disease 51-75 Appropriate, Reports, Acute, Presents, Daily
Prevention AND Patient
Education
Management OF Acute AND 76-100 Appropriate, According, Diabetes, Finding, Presents
Chronic Illness Across THE
Lifespan
Women S Health AND 101-125 Finding, Presents, History, Appropriate, Anemia
Prenatal/postpartum CARE
Pediatric AND Adolescent 126-145 Appropriate, Finding, Acute, Metformin, Presents
Primary CARE
TOTAL 145 All questions include answers and detailed rationales
,Section A - Advanced Health Assessment AND Diagnostic
Reasoning
Q1.
A patient with type 2 diabetes has an eGFR of 42 mL/min/1.73 m² and albuminuria. Which
medication class provides the strongest evidence for slowing CKD progression in this
scenario?
A. SGLT2 inhibitor B. Loop diuretic
C. Beta-blocker D. Calcium channel blocker
Correct: A - SGLT2 inhibitor
Rationale:SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin) have robust evidence for
slowing CKD progression and reducing cardiovascular events in diabetic kidney disease,
even in moderate renal impairment. Loop diuretics manage volume but do not slow
progression. Beta-blockers and calcium channel blockers lack primary renoprotective benefit
in this context.
Why the other answers are wrong:
B. Loop diuretics provide symptomatic volume control but do not confer renoprotection or slow
CKD progression.
C. Beta-blockers are used for cardiac indications and do not have primary evidence for slowing
diabetic kidney disease.
D. Calcium channel blockers may lower blood pressure but are not first-line for renoprotection
in diabetic CKD.
Reference: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD; ADA
Standards of Care 2026.
Q2.
A patient presents with sudden-onset unilateral facial droop, arm weakness, and slurred
speech that began 45 minutes ago. Which action is the immediate priority?
A. Administer aspirin 325 mg orally B. Activate emergency stroke protocol and
obtain non-contrast head CT
C. Obtain carotid ultrasound in the office D. Prescribe tissue plasminogen activator
(tPA) in the clinic
Correct: B - Activate emergency stroke protocol and obtain non-contrast head CT
Page 3
, Section A - Advanced Health Assessment AND Diagnostic Reasoning
Rationale: Acute stroke symptoms within the thrombolytic window require immediate
emergency activation and non-contrast head CT to rule out hemorrhage before any
reperfusion therapy. Aspirin is not given before imaging in acute stroke. Carotid ultrasound is
not emergent, and tPA is administered in a certified stroke center, not a primary care office.
Why the other answers are wrong:
A. Aspirin is contraindicated before ruling out hemorrhagic stroke and is not the immediate
priority.
C. Carotid ultrasound evaluates stenosis but is not part of acute stroke emergency
management.
D. tPA must be given in a hospital setting after imaging; the FNP's role is rapid recognition and
transfer.
Reference: AHA/ASA 2025 Guideline for the Early Management of Patients With Acute Ischemic Stroke.
Q3.
A patient with major depressive disorder has had inadequate response to an SSRI at
optimal dose for 8 weeks. Which is the most appropriate next step?
A. Add buspirone B. Switch to a different SSRI or SNRI
C. Augment with a low-dose antipsychotic D. Discontinue pharmacotherapy and start
psychotherapy alone
Correct: B - Switch to a different SSRI or SNRI
Rationale:After inadequate response to an adequate trial of an SSRI, switching to a different
SSRI or an SNRI is a recommended strategy. Augmentation with atypical antipsychotics or
adding buspirone are options for partial response, but switching is first-line when there is no
response. Monotherapy with psychotherapy alone is insufficient for moderate-to-severe
depression.
Why the other answers are wrong:
A. Buspirone augmentation is not first-line for inadequate SSRI response and has limited
evidence for depression.
C. Antipsychotic augmentation is typically reserved for partial response or treatment-resistant
depression after other steps.
D. Discontinuing pharmacotherapy is not recommended for moderate-to-severe depression;
combined treatment is preferred.
Reference: APA Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2025;
STAR*D findings.
Q4.
Which finding best supports a diagnosis of bacterial rather than viral conjunctivitis?
A. Bilateral watery discharge B. Preauricular lymphadenopathy
Page 4
